Now live: Pro — the full 13F research suite for serious investorsSee pricing →
Atlas Venture Associates IX, LLC

Q4 2022 · 13F-HR

Atlas Venture Associates IX, LLCholdings as filed

Filed 2023-01-31 · accession 0001104659-23-008303

$20.1M
Reported value
6
Positions
2022-12-31
Period end
View analyzed profile →PRO

Holdings as filed

CUSIPTickerIssuerValue% port.SharesClassVoting
83067L109SKILLZ INC$11.6M57.7%22,909,859CommonSOLE
86877M209SURFACE ONCOLOGY INC$2.4M12.0%2,945,453CommonSOLE
84833T103SPROSPERO THERAPEUTICS INC$2.4M11.9%1,376,968CommonSOLE
87166L100SYNLOGIC INC$2.0M10.0%2,651,963CommonSOLE
83304A106SNAPSNAP INC$1.3M6.69%150,160CommonNONE
45826J105NTLAINTELLIA THERAPEUTICS INC$348,9001.74%10,000CommonSOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.